These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 32661752)

  • 1. Preclinical and clinical studies of photobiomodulation therapy for macular oedema.
    Shen W; Teo KYC; Wood JPM; Vaze A; Chidlow G; Ao J; Lee SR; Yam MX; Cornish EE; Fraser-Bell S; Casson RJ; Gillies MC
    Diabetologia; 2020 Sep; 63(9):1900-1915. PubMed ID: 32661752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE).
    Kim JE; Glassman AR; Josic K; Melia M; Aiello LP; Baker C; Eells JT; Jampol LM; Kern TS; Marcus D; Salehi-Had H; Shah SN; Martin DF; Stockdale CR; Sun JK;
    Ophthalmol Retina; 2022 Apr; 6(4):298-307. PubMed ID: 34628066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety Profile of Slit-Lamp-Delivered Retinal Laser Photobiomodulation.
    Ao J; Chidlow G; Wood JPM; Casson RJ
    Transl Vis Sci Technol; 2020 Mar; 9(4):22. PubMed ID: 32818109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Invasive Treatment of Early Diabetic Macular Edema by Multiwavelength Photobiomodulation with the Valeda Light Delivery System.
    Kaymak H; Munk MR; Tedford SE; Croissant CL; Tedford CE; Ruckert R; Schwahn H
    Clin Ophthalmol; 2023; 17():3549-3559. PubMed ID: 38026594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photobiomodulation preserves mitochondrial redox state and is retinoprotective in a rodent model of retinitis pigmentosa.
    Gopalakrishnan S; Mehrvar S; Maleki S; Schmitt H; Summerfelt P; Dubis AM; Abroe B; Connor TB; Carroll J; Huddleston W; Ranji M; Eells JT
    Sci Rep; 2020 Nov; 10(1):20382. PubMed ID: 33230161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial.
    Glassman AR; Baker CW; Beaulieu WT; Bressler NM; Punjabi OS; Stockdale CR; Wykoff CC; Jampol LM; Sun JK;
    JAMA Ophthalmol; 2020 Apr; 138(4):341-349. PubMed ID: 32077907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of transfoveal subthreshold diode micropulse laser for fovea-involving diabetic macular edema in eyes with good visual acuity.
    Luttrull JK; Sinclair SH
    Retina; 2014 Oct; 34(10):2010-20. PubMed ID: 24837050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.
    Bahrami B; Hong T; Zhu M; Schlub TE; Chang A
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1133-1140. PubMed ID: 28238195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophy of the central neuroretina in patients treated for diabetic macular edema.
    Karst SG; Schuster M; Mitsch C; Meyer EL; Kundi M; Scholda C; Schmidt-Erfurth UM
    Acta Ophthalmol; 2019 Dec; 97(8):e1054-e1061. PubMed ID: 31228332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
    Maturi RK; Glassman AR; Liu D; Beck RW; Bhavsar AR; Bressler NM; Jampol LM; Melia M; Punjabi OS; Salehi-Had H; Sun JK;
    JAMA Ophthalmol; 2018 Jan; 136(1):29-38. PubMed ID: 29127949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluate the effectiveness of laser therapy in the treatment of diabetic maculopathy].
    Mrugacz M; Krajewska M; Bryl A; Szuszkiewicz M
    Pol Merkur Lekarski; 2013 Jun; 34(204):351-4. PubMed ID: 23882935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
    Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
    Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial.
    Ahmadieh H; Nourinia R; Hafezi-Moghadam A; Sabbaghi H; Nakao S; Zandi S; Yaseri M; Tofighi Z; Akbarian S
    Br J Ophthalmol; 2019 Jul; 103(7):922-927. PubMed ID: 30150280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-spot subthreshold infrared laser to treat diabetic macular edema.
    Squirrell DM; Stewart AW; Joondeph BC; Danesh-Meyer HV; McGhee CN; Donaldson ML
    Retina; 2008 Apr; 28(4):615-21. PubMed ID: 18398365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results.
    Payne JF; Wykoff CC; Clark WL; Bruce BB; Boyer DS; Brown DM;
    Br J Ophthalmol; 2021 Feb; 105(2):253-257. PubMed ID: 32303499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
    Mitchell P; Bandello F; Schmidt-Erfurth U; Lang GE; Massin P; Schlingemann RO; Sutter F; Simader C; Burian G; Gerstner O; Weichselberger A;
    Ophthalmology; 2011 Apr; 118(4):615-25. PubMed ID: 21459215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
    Iacono P; Parodi MB; Scaramuzzi M; Bandello F
    Br J Ophthalmol; 2017 Jun; 101(6):791-795. PubMed ID: 27625164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
    Bressler NM; Beaulieu WT; Glassman AR; Blinder KJ; Bressler SB; Jampol LM; Melia M; Wells JA;
    JAMA Ophthalmol; 2018 Mar; 136(3):257-269. PubMed ID: 29392288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results.
    Lim LL; Morrison JL; Constantinou M; Rogers S; Sandhu SS; Wickremasinghe SS; Kawasaki R; Al-Qureshi S
    Clin Exp Ophthalmol; 2016 May; 44(4):233-42. PubMed ID: 26871700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.